Merck (NYSE: NYSE: MRK ) is yet another pharmaceutical company that has been on my radar as the industry has grappled with a wide decline since 2024 . With that in mind and theAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anything that has been unloved for unjus ...